Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tamarine is an over-the-counter herbal laxative marmalade developed and marketed by Gerolymatos International. It is primarily indicated for the short-term treatment of occasional constipation. The formulation is a combination of natural plant extracts, with the primary active pharmacological component being senna (Cassia angustifolia), which provides a stimulant laxative effect through its sennoside content. Other ingredients typically include tamarind (Tamarindus indica), cassia fistula, and coriander, which contribute to the product's jam-like consistency and assist in its laxative properties. Tamarine works by stimulating the enteric nervous system and the colonic mucosa, thereby increasing intestinal motility and promoting bowel evacuation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Tamarine.